| | | | | |
AGIO Agios Pharmaceuticals, Inc. | €23.8614 | +4.40% | €1.50B | €585.53K | |
SGRY Surgery Partners, Inc. Common Stock | €11.6397 | -1.96% | €1.50B | €1.21M | |
GAB The Gabelli Equity Trust Inc. | €4.8369 | -0.18% | €1.50B | €664.65K | |
HURN Huron Consulting Group Inc. | €90.3198 | -1.74% | €1.50B | €170.85K | |
ENVX Enovix Corporation Common Stock | €7.0873 | -4.64% | €1.50B | €6.26M | |
PAYO Payoneer Global Inc. Common Stock | €4.3843 | -4.95% | €1.50B | €4.00M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | €12.8037 | -0.67% | €1.49B | €139.62K | |
STGW Stagwell Inc. Class A Common Stock | €5.6819 | -8.47% | €1.49B | €1.48M | |
CASH Pathward Financial, Inc. Common Stock | €66.9757 | -4.58% | €1.49B | €320.14K | |
SNDX Syndax Pharmaceuticals, Inc. | €15.8171 | -0.25% | €1.49B | €1.07M | |
STRA Strategic Education, Inc. Common Stock | €68.1483 | -0.15% | €1.49B | €152.15K | |
CAPR Capricor Therapeutics Inc | €23.8571 | +1.21% | €1.49B | €573.17K | |
AAPG Ascentage Pharma Group International American Depository Shares | €15.3687 | -3.39% | €1.49B | €19.46K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | €7.0614 | -1.68% | €1.49B | €6.43M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | €21.5550 | +2.97% | €1.49B | €225.46K | |
